Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You're welcome frans...$MDXH
476k on bid .16...$VCIG
THE OFFERING
149,618,942 / 9,099,181 = 16.44 ⚪️ Price .146 / 16.44 = .00888 "dilution hit" to share price, at worst, $0.137, in exchange for $1,000,000. How much does the 9 million share buyer desire for the 1 million dollar investment? Could possibly see 100%-300% appreciation pretty quick depending, of course, on developments...JMO 😺
$VCIG
See if the broker-dealers-distributors CHURN the shit out of this.
$MDXH -23% at 1.95 in premarket. Looking for 4-6? Gonna take a lot of churning to grab $40,000,000 out of the marketplace, JMO
MDxHealth Announces Pricing of Offering of Ordinary Shares
September 25 2024 - 9:31PM
IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it has priced a registered public offering of 20,000,000 ordinary shares of the Company without nominal value (“Ordinary Shares”) in a registered public offering (the “Offering”) at a price to the public of $2.00 per Ordinary Share for total gross proceeds of $40.0 million before deducting commissions and estimated offering expenses. A strategic partner is purchasing 1,500,000 Ordinary Shares in this Offering directly from the Company rather than through the underwriters. In connection with the Offering, mdxhealth has granted the underwriters an option to purchase up to an additional 2,775,000 Ordinary Shares, on the same terms and conditions.
The closing of the Offering is expected to occur on September 27, 2024, subject to the satisfaction of customary closing conditions. The new Ordinary Shares will have the same rights and benefits as, and rank pari passu in all respects, including as to entitlement to dividends and distributions, with, the Company’s existing and outstanding Ordinary Shares and will be entitled to distributions in respect of which the relevant record date or due date falls on or after the date of issue of the new shares.
Mdxhealth intends to use the net proceeds from the Offering for general corporate and working capital purposes, including to fund product development efforts and commercial activities.
TD Cowen and William Blair are acting as joint book-running managers and BTIG, LLC and Lake Street Capital Markets are acting as passive bookrunners for the Offering.
The Ordinary Shares described above are being offered by mdxhealth pursuant to a registration statement previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement relating to the Offering has been filed with the SEC and is available on the SEC’s website at http://www.sec.gov. This press release does not constitute an offer to sell or a solicitation of an offer to buy securities of the Company nor shall there be any offer, solicitation or sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities, if at all, has been or will be made in accordance with the registration requirements of the United States Securities Act of 1933 and the European Prospectus Regulation (Regulation (EU) 2017/1129), as relevant.
Copies of the preliminary prospectus supplement, and accompanying base prospectus relating to this offering, may be obtained from TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, by email at TD.ECM_Prospectus @russwinter; William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone at (800) 621-0687, or by email at prospectus@williamblair.com; BTIG, LLC, 350 Bush Street, 9th FL, San Francisco, CA 94104, Attention: Syndicate Department (415-248-2200) or by email at prospectusdelivery@btig.com; and Lake Street Capital Markets, LLC, Attention: Syndicate Department, 920 Second Avenue South, Suite 700 Minneapolis, MN 55402, by telephone at (612) 326-1305, or by email at syndicate@lakestreetcm.com.
For more information:
mdxhealth
info@mdxhealth.com
LifeSci Advisors (IR & PR)
US: +1 949 271 9223
ir@mdxhealth.com
See if the broker-dealers-distributors CHURN the shit out of this.
$MDXH -23% at 1.95 in premarket. Looking for 4-6? Gonna take a lot of churning to grab $40,000,000 out of the marketplace, JMO
MDxHealth Announces Pricing of Offering of Ordinary Shares
September 25 2024 - 9:31PM
IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it has priced a registered public offering of 20,000,000 ordinary shares of the Company without nominal value (“Ordinary Shares”) in a registered public offering (the “Offering”) at a price to the public of $2.00 per Ordinary Share for total gross proceeds of $40.0 million before deducting commissions and estimated offering expenses. A strategic partner is purchasing 1,500,000 Ordinary Shares in this Offering directly from the Company rather than through the underwriters. In connection with the Offering, mdxhealth has granted the underwriters an option to purchase up to an additional 2,775,000 Ordinary Shares, on the same terms and conditions.
The closing of the Offering is expected to occur on September 27, 2024, subject to the satisfaction of customary closing conditions. The new Ordinary Shares will have the same rights and benefits as, and rank pari passu in all respects, including as to entitlement to dividends and distributions, with, the Company’s existing and outstanding Ordinary Shares and will be entitled to distributions in respect of which the relevant record date or due date falls on or after the date of issue of the new shares.
Mdxhealth intends to use the net proceeds from the Offering for general corporate and working capital purposes, including to fund product development efforts and commercial activities.
TD Cowen and William Blair are acting as joint book-running managers and BTIG, LLC and Lake Street Capital Markets are acting as passive bookrunners for the Offering.
The Ordinary Shares described above are being offered by mdxhealth pursuant to a registration statement previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”). A preliminary prospectus supplement relating to the Offering has been filed with the SEC and is available on the SEC’s website at http://www.sec.gov. This press release does not constitute an offer to sell or a solicitation of an offer to buy securities of the Company nor shall there be any offer, solicitation or sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification or publication of an offering prospectus under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities, if at all, has been or will be made in accordance with the registration requirements of the United States Securities Act of 1933 and the European Prospectus Regulation (Regulation (EU) 2017/1129), as relevant.
Copies of the preliminary prospectus supplement, and accompanying base prospectus relating to this offering, may be obtained from TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, NY 10017, by email at TD.ECM_Prospectus @russwinter; William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, or by telephone at (800) 621-0687, or by email at prospectus@williamblair.com; BTIG, LLC, 350 Bush Street, 9th FL, San Francisco, CA 94104, Attention: Syndicate Department (415-248-2200) or by email at prospectusdelivery@btig.com; and Lake Street Capital Markets, LLC, Attention: Syndicate Department, 920 Second Avenue South, Suite 700 Minneapolis, MN 55402, by telephone at (612) 326-1305, or by email at syndicate@lakestreetcm.com.
For more information:
mdxhealth
info@mdxhealth.com
LifeSci Advisors (IR & PR)
US: +1 949 271 9223
ir@mdxhealth.com
Yes I do, Tiger Money 😺
I would buy as much as I could of this the only restraint being the unpredictability of the USCOG (US communist occupation government) leading up to the 2024 election and shortly thereafter...February 2025...
In "normal times" load the boat here, JMO
👉️ https://ir.modular-medical.com/data/files/ModularMedical-InvestorPresentation-September-10-2024.pdf
$MODD @ 2.37
$RZLV +59% @ 7.80 on news...
Don't have time to post it right now but take a look at the CEO's past. Company has a market cap of over $1.3B, I think it is, and they are just getting started as a public entity...
Very interesting, thanks powerbattles!
$SLXN +15% @ .88 on NEWS/volume 😺
$SLXN +15% @ .88 on NEWS/volume 😺
$ATPC +11% @ 1.94 volume surge... 😺
$ASNS +40% @ 2.10 on NEWS/volume AH
Actelis Receives New Significant Order for Major U.S. Department of Aerial Transportation Agency
September 09 2024 - 4:05P
Actelis Networks, Inc. (NASDAQ:ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced that it has received a new significant order for a major aerial transportation agency operating underneath the umbrella of the U.S. Department of Transportation. Actelis continues to expand its presence in the transportation sector with its cyber-hardened, hybrid-fiber networking technology that is used at traffic intersections, along major highways and railways, and at international airports around the world.
Over the past four months, the company has announced several key intelligent transportation sector wins including a $2.3 Million Order for delivery of a new hybrid-fiber intelligent networking solution for Washington D.C.’s Department of Transportation in May, a $300,000 new order for an Italian national transportation infrastructure project in June, and a $260,000 Order for a major Mid-Atlantic US county traffic system modernization project in July. Actelis’ unique ability to help agencies greatly accelerate project timelines and save tremendous amounts of money on engineering and construction costs has helped secure these notable projects.
“We’re thrilled with the significant progress we’ve made in the intelligent aerial transportation sector,” said Tuvia Barlev, Chairman and CEO of Actelis. “Our customers deliver critical services to their communities, and we’re proud to play a key role by providing the essential connectivity and data transmission solutions they need, all secured by our cyber-hardened platform to protect their networks.”
This new order will enable Actelis to support the agency with a wide range of applications, including connecting remote facilities, backhauling radar networks, and consolidating T1 lines over IP for fiber projects. The flexibility of Actelis’ solutions is crucial in overcoming common project hurdles for its customers.
“Our solution eliminates many obstacles by delivering fiber-grade connectivity instantly, regardless of the existing wiring in the customer’s network,” Barlev continued. “This immediately upgrades their network, enabling the rapid deployment of IoT devices and broadband services without the lengthy delays of installing new cabling.”
About Actelis Networks, Inc.
Actelis Networks, Inc. (NASDAQ: ASNS) is a market leader in hybrid fiber-copper, cyber-hardened networking solutions for rapid deployment in wide-area IoT applications, including government, ITS, military, utility, rail, telecom, and campus networks. Actelis’ innovative portfolio offers fiber-grade performance with the flexibility and cost-efficiency of hybrid fiber-copper networks. Through its "Cyber Aware Networking" initiative, Actelis also provides AI-based cyber monitoring and protection for all edge devices, enhancing network security and resilience.
For more information, please visit https://actelis.com/.
$ASNS
Nice day @ $BNRG 👉️ Brenmiller Energy Further Fortifies Balance Sheet with $2 Million Raised from At-The-Market Equity Offering at $2.19 per Share
September 09 2024 - 8:30AM Business Wire
• Company’s intention going forward is to not utilize the ATM facility under $3.00 per share
• Heat-as-a-Service (“HaaS”) projects with recurring revenues to be funded mainly using third-party project finance, not equity funding, with an aim to enhance shareholder value while simultaneously accelerating Company’s capacity to execute on a project pipeline potentially worth up to $500 million in value
Brenmiller Energy Ltd. (“Brenmiller”, “Brenmiller Energy” or the “Company”) (Nasdaq: BNRG), a leading global provider of thermal energy storage (“TES”) solutions for industrial and utility customers, today issued an update on its balance sheet and recent commercial developments.
On August 30, 2024, Brenmiller raised approximately $2.0 million in gross proceeds through its existing At-the-Market (“ATM”) equity offering facility with the sale of 914,000 ordinary shares at an average price per share of approximately $2.19. As a result, the Company now has 7,094,791 ordinary shares issued and outstanding. Since the beginning of 2024, the Company has raised approximately $10.8 million in gross proceeds. The Company also signed a definitive agreement for the sale of an additional 1,000,000 ordinary shares through a $1.05 million private placement equity investment priced at a 52% premium to market on August 2, 2024 from an existing institutional shareholder, the completion of which is subject to certain closing conditions.
"We are currently working hard to increase the Company's commercial opportunity pipeline with emphasis on HaaS projects, to convert these opportunities into commercial projects, and to improve our financial position by establishing effective financing solutions through equity and debt while continuing our commitment to operational excellence. I want to clearly point out that most of the HaaS projects in our pipeline, including our latest contract with Partner in Pet Food in Europe, will be funded through third-party project financing and will not require extraordinary project-level investment from Brenmiller," stated Brenmiller Chairman and Chief Executive Officer Avi Brenmiller.
Brenmiller Energy delivers low-carbon heat through direct technology sales and a HaaS model. The latter lowers energy transition costs for customers and allows Brenmiller to capture additional recurring revenues through participation in energy market programs.
About bGen™
bGen™, Brenmiller’s TES system, converts electricity into heat to power sustainable industrial processes at a price that is competitive with natural gas. The bGen™ charges by capturing low-cost electricity from renewables or the grid and stores it in crushed rocks. It then discharges steam, hot water or hot air on demand according to customer requirements. The bGen™ also supports the development of utility-scale renewables by providing critical flexibility and grid-balancing capabilities. bGen™ was named among TIME’s Best Inventions of 2023 in the Green Energy category.
$BNRG
Tanking some now (@1.69), be looking for a "decent entry" point...no fear of a(n) RS JMO
Grabbed a starter down here...may get out if there's a good bounce otherwise longish...
As of May 6, 2024, there were 3,117,049 shares of the registrant’s Common Stock issued and outstanding.
Cash & Equivs $9.4M with a quarterly Burn Rate (loss) of approx $2.5M per Q. They may have to have another offering before they receive, hopefully soon, FDA Clearance to market & sell...looks like a pretty safe long (in & out as it goes) play, very interesting product JMO 😺
$INBS FINS as of March 31, 2024:
Spot on, Invest... after the SEC cleaned-up the OTC, & thereby left no alternative except for the NASDAQ itself to become increasingly CORRUPT!! (Funny stuff, except when one gets SUCKERED by these daily GAP-&-DROPPERS!!)...after the OTC died came over to the NASDAQ and got fooled a few times by the brazen p&ders...in & out...I don't care what it is...however, I do have a shit ton of bookmarkers (stocks with small investment dollars in them)...can't go heavy long until well into 2025...if then even...
Absolutely, friend, more P&Ds on NASDAQ, nowadays, than the OTC in it's prime...
😺 In & out, Invest, I know I don't have to remind you of that, GLTY...
Lol, sorry, not a tool, just going from aft and premarkert into the regular market, the Rubicon, point of no return...a lot of these p&d pOps like to do it in the dead of night under cover of dark...these ihub charts (classic) illuminate the activity...but ya gotta screen capture the activity...
$INBS
Conversion Price. The conversion price shall be 80% of the average closing price of the Company’s common stock over the last five (5) trading days prior to conversion (the “Conversion Price”).
I believe the shares are restricted for 6 months as they are not registered shares.
👉️ Form 6-K 9/6/24
$VCIG
MODD 💢 Business Model
MODD 👉️ FINS
Poised to Launch, early 2025, potential is awesome. JMO
Burn rate (net loss) is $4 million per quarter (last Q). MODD will likely need to raise capital.
The earlier the commercialization in "early 2025" the better.
Little DEBT, Assets $10M, Liabilities $2M, Stockholders' Equity $8M. Poised for potential. 😺
$MODD
$MODD
💢 NASDAQ: MODD 💢
👉️ https://www.modular-medical.com/modd1
$MODD